Developer docs
API playgroundTry for free, no card

Search company profiles

Dura Medical

Full company profile

uuid003xeh4

Namestring
Dura Medical
Legal namestring
Dura Medical LLC
Websiteurl
duramedical.us
Company typeenum
Private
Founded yearint
2018
Descriptiontext

Dura Medical LLC is a private, founder-owned outpatient behavioral health practice headquartered in Naples, Florida, with additional sites in Fort Myers (owned) and West Palm Beach (via partnership with Hope Therapeutics). The practice specializes in treatment-resistant mental health conditions, treating patients aged 6 and older for depression, anxiety, PTSD, OCD, ADHD, bipolar disorder, chronic pain (CRPS, fibromyalgia, migraines, neuropathic pain, RLS), postpartum depression, and suicidal ideation. The clinical team comprises a board-certified psychiatrist (Medical Director), a CRNA founder, psychiatric nurse practitioners, licensed mental health counselors, social workers, and registered nurses across multiple locations.

The service portfolio centers on three advanced interventional treatments — intravenous ketamine infusion therapy, Ketamine-Assisted Psychotherapy (KAP), and FDA-cleared theta burst Transcranial Magnetic Stimulation (TMS) using MagVenture equipment — supplemented by Spravato (esketamine nasal spray) under REMS-monitored clinic administration, EMDR therapy, talk therapy, medication management, and telemedicine consultations via Doxy.me and Zoom. Vitamin IV therapy is offered as a complementary wellness service. The practice advertises outcome claims of 75% patient relief rate for depression via ketamine and 50-80% symptom improvement across mood disorders, with a Fast Track to Wellness program enabling next-business-day appointments for ketamine and TMS patients.

Revenue is generated on a professional services / fee-for-service basis across six identifiable streams: ketamine infusion sessions, TMS sessions, Spravato treatments, psychotherapy/counseling, medication management, and telemedicine consultations. Pricing is not publicly disclosed; CareCredit financing is accepted. The go-to-market is hybrid: direct-to-consumer via website, blog content, organic social (Facebook, LinkedIn), and online appointment booking, combined with a provider referral program for physicians and healthcare professionals. No external funding, M&A activity, or institutional ownership has been disclosed, and the practice operates as a typical independent specialty medical clinic with Athena Health as the EHR/patient portal.

Short descriptiontext

Dura Medical is a Florida-based outpatient behavioral health practice offering ketamine infusion therapy, TMS, Spravato, EMDR, and psychotherapy for treatment-resistant mental health conditions, operating across three locations in Naples, Fort Myers, and West Palm Beach.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersNaples, United States
HQ citystring
Naples
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
outpatient behavioral health, ketamine infusion therapy, transcranial magnetic stimulation, treatment-resistant depression, telepsychiatry services
NAICS code2 codes
  • Outpatient Mental Health and Substance Abuse Centers621420
  • Offices of Physicians, Mental Health Specialists621112
SIC code2 codes
  • Services-Offices & Clinics Of Doctors Of Medicine8011
  • Services-Specialty Outpatient Facilities, Nec8093
Product category
Outpatient Behavioral Health Services
Social media profiles2 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model6 records
1Ketamine Infusion Therapy Services
TypeProfessional Services
Description

Revenue from ketamine infusion therapy sessions for treatment-resistant depression, anxiety, PTSD, and chronic pain conditions. Sessions typically require 2-4 hours including observation/recovery time.

duramedical.us
2TMS Therapy Services
TypeProfessional Services
Description

Revenue from transcranial magnetic stimulation sessions. FDA-cleared theta burst treatment available in 3.5-minute sessions or standard 4-minute treatments.

duramedical.us
3Spravato Treatment
TypeProfessional Services
Description

Revenue from FDA-approved esketamine nasal spray treatments for treatment-resistant depression with two-hour observation period per session.

duramedical.us
4Psychotherapy and Counseling
TypeProfessional Services
Description

Revenue from talk therapy, EMDR therapy, and other counseling services provided by licensed mental health professionals including LMHCs, LCSWs, LMFTs, and psychiatric nurse practitioners.

duramedical.us
5Medication Management
TypeProfessional Services
Description

Revenue from psychiatric medication evaluation, prescribing, and ongoing management services for mental health disorders.

duramedical.us
6Telemedicine Services
TypeProfessional Services
Description

Revenue from remote video consultations via secure telemedicine platform, enabling ongoing patient care without requiring in-person visits.

duramedical.us
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Marketing or Sales, Infrastructure, Supply Chain, Technology or R&D
Pricing details1 tier
1Ketamine infusion therapy - quote-based pricing
ModelOtherBilling cadencePay-as-you-go
Notes

Typical initial treatments require 2-3 hours including observation/recovery; higher doses may require 4 hours with extended observation. Quote-based pricing requires consultation.

duramedical.us
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Dura Medical is an outpatient behavioral health practice that evaluates and treats patients with depression, PTSD, anxiety, OCD, postpartum depression, bipolar disorder, and chronic pain. It delivers interventional therapies (IV ketamine, ketamine-assisted psychotherapy, TMS, Spravato, vitamin infusions) alongside psychotherapy, EMDR, and medication management, with both in-clinic and telemedicine delivery across its Florida locations.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 75% of patients find relief through ketamine infusion therapy for depression
+3 more records
Product overview1 text field

Dura Medical is a behavioral health practice offering a multi-modal mental health treatment platform combining novel neurobiological interventions with traditional psychotherapy and medication management. The core portfolio centers on three advanced interventional treatments — Ketamine Therapy (IV infusion), Ketamine-Assisted Psychotherapy (KAP), Transcranial Magnetic Stimulation (TMS) using MagVenture equipment with FDA-cleared theta burst, and Spravato® (esketamine nasal spray) — supplemented by Talk Therapy/Psychotherapy, EMDR, Medication Management, Telemedicine (via Doxy.me and Zoom), and Vitamin Therapy. These services collectively treat a wide range of conditions including treatment-resistant depression, anxiety, PTSD, OCD, bipolar disorder, ADHD, chronic pain conditions (CRPS, fibromyalgia, migraines, neuropathic pain, RLS), postpartum depression, and suicidal ideation. The practice operates in Naples, Fort Myers, and West Palm Beach, Florida, with a Fast Track to Wellness program offering next-business-day appointments for ketamine and TMS patients.

Product and service9 records
1Ketamine Therapy
CategoryInterventional psychiatry
2Ketamine-Assisted Psychotherapy
CategoryInterventional psychiatry
3TMS Therapy
CategoryInterventional psychiatry
4Spravato Treatment
CategoryInterventional psychiatry
5EMDR Therapy
CategoryPsychotherapy
6Talk Therapy (Psychotherapy)
CategoryPsychotherapy
7Medication Management
CategoryPsychiatric services
8Telemedicine
CategoryTelepsychiatry
9Vitamin Therapy
CategoryAdjunctive wellness therapy
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partnership arrangement at West Palm Beach location (1515 N Flagler Dr - Ste 800 West Palm Beach, FL 33407) where Hope Therapeutics operates. Dura Medical maintains presence at this location for patient referrals and services.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Large-scale digital mental health platform offering therapy, medication management, and broader psychiatric services; competes for the same patient segment but as a broader incumbent without Dura Medical's interventional depth.

TypeDirect peer
Description

Operated multi-city ketamine-assisted psychotherapy and interventional psychiatry clinics before winding down U.S. operations; directly comparable multi-modal treatment model targeting treatment-resistant depression and anxiety.

TypeEmerging player
Description

Telehealth mental health provider offering medication management and therapy, with growing interventional psychiatry capabilities; partial overlap with Dura Medical's medication management and telemedicine streams.

TypeDirect peer
Description

At-home ketamine therapy platform with clinician-supervised sessions; comparable ketamine-based treatment offering for depression and anxiety, though delivered remotely rather than in clinic.

TypeDirect peer
Description

Regional ketamine infusion clinics operating in the same Florida market segment; directly comparable outpatient ketamine delivery model for treatment-resistant depression and pain.

TypeBroad incumbent
Description

National chain operating dedicated TMS treatment centers for depression and OCD; directly comparable on TMS delivery though lacks Dura Medical's ketamine and Spravato offerings.

TypeDirect peer
Description

Multi-location interventional psychiatry practice offering ketamine infusion, TMS, and Spravato with a similar treatment-resistant mental health focus and clinical model.

TypeRegional player
Description

Other regional psychiatry and behavioral health practices in the Florida market that compete for the same southwest Florida patient base and provider referrals, though with less specialized interventional offerings.

TypeEmerging player
Description

Online psychiatry platform connecting patients with psychiatrists for medication management and therapy; comparable on the psychiatric care side but lacks Dura Medical's in-clinic interventional modalities.

TypeDirect peer
Description

Outpatient interventional psychiatry clinics offering ketamine infusion, Spravato, TMS, and medication management for treatment-resistant conditions — a near-identical service mix to Dura Medical.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

API detail
Has APIbool
No

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Dura Medical

Outpatient Behavioral Health Servicesduramedical.us

Dura Medical is a Florida-based outpatient behavioral health practice offering ketamine infusion therapy, TMS, Spravato, EMDR, and psychotherapy for treatment-resistant mental health conditions, operating across three locations in Naples, Fort Myers, and West Palm Beach.

What Dura Medical does

Dura Medical LLC is a private, founder-owned outpatient behavioral health practice headquartered in Naples, Florida, with additional sites in Fort Myers (owned) and West Palm Beach (via partnership with Hope Therapeutics). The practice specializes in treatment-resistant mental health conditions, treating patients aged 6 and older for depression, anxiety, PTSD, OCD, ADHD, bipolar disorder, chronic pain (CRPS, fibromyalgia, migraines, neuropathic pain, RLS), postpartum depression, and suicidal ideation. The clinical team comprises a board-certified psychiatrist (Medical Director), a CRNA founder, psychiatric nurse practitioners, licensed mental health counselors, social workers, and registered nurses across multiple locations.

The service portfolio centers on three advanced interventional treatments — intravenous ketamine infusion therapy, Ketamine-Assisted Psychotherapy (KAP), and FDA-cleared theta burst Transcranial Magnetic Stimulation (TMS) using MagVenture equipment — supplemented by Spravato (esketamine nasal spray) under REMS-monitored clinic administration, EMDR therapy, talk therapy, medication management, and telemedicine consultations via Doxy.me and Zoom. Vitamin IV therapy is offered as a complementary wellness service. The practice advertises outcome claims of 75% patient relief rate for depression via ketamine and 50-80% symptom improvement across mood disorders, with a Fast Track to Wellness program enabling next-business-day appointments for ketamine and TMS patients.

Revenue is generated on a professional services / fee-for-service basis across six identifiable streams: ketamine infusion sessions, TMS sessions, Spravato treatments, psychotherapy/counseling, medication management, and telemedicine consultations. Pricing is not publicly disclosed; CareCredit financing is accepted. The go-to-market is hybrid: direct-to-consumer via website, blog content, organic social (Facebook, LinkedIn), and online appointment booking, combined with a provider referral program for physicians and healthcare professionals. No external funding, M&A activity, or institutional ownership has been disclosed, and the practice operates as a typical independent specialty medical clinic with Athena Health as the EHR/patient portal.

Dura Medical firmographics

Firmographics
Name
Dura Medical
Legal name
Dura Medical LLC
Website
https://duramedical.us
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
11–50 employees
Short description
Dura Medical is a Florida-based outpatient behavioral health practice offering ketamine infusion therapy, TMS, Spravato, EMDR, and psychotherapy for treatment-resistant mental health conditions, operating across three locations in Naples, Fort Myers, and West Palm Beach.
Ownership category
akta.pro rank

Where Dura Medical is headquartered

Location

Headquarters

HQ city
Naples
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Dura Medical business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Infrastructure, Supply Chain, Technology or R&D

Revenue model

  1. Ketamine Infusion Therapy Services: Revenue from ketamine infusion therapy sessions for treatment-resistant depression, anxiety, PTSD, and chronic pain conditions. Sessions typically require 2-4 hours including observation/recovery time.
  2. TMS Therapy Services: Revenue from transcranial magnetic stimulation sessions. FDA-cleared theta burst treatment available in 3.5-minute sessions or standard 4-minute treatments.
  3. Spravato Treatment: Revenue from FDA-approved esketamine nasal spray treatments for treatment-resistant depression with two-hour observation period per session.
  4. Psychotherapy and Counseling: Revenue from talk therapy, EMDR therapy, and other counseling services provided by licensed mental health professionals including LMHCs, LCSWs, LMFTs, and psychiatric nurse practitioners.
  5. Medication Management: Revenue from psychiatric medication evaluation, prescribing, and ongoing management services for mental health disorders.
  6. Telemedicine Services: Revenue from remote video consultations via secure telemedicine platform, enabling ongoing patient care without requiring in-person visits.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goKetamine infusion therapy - quote-based pricing

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

Dura Medical product offering

Product offering

Core offering

Dura Medical is an outpatient behavioral health practice that evaluates and treats patients with depression, PTSD, anxiety, OCD, postpartum depression, bipolar disorder, and chronic pain. It delivers interventional therapies (IV ketamine, ketamine-assisted psychotherapy, TMS, Spravato, vitamin infusions) alongside psychotherapy, EMDR, and medication management, with both in-clinic and telemedicine delivery across its Florida locations.

Product overview

Dura Medical is a behavioral health practice offering a multi-modal mental health treatment platform combining novel neurobiological interventions with traditional psychotherapy and medication management. The core portfolio centers on three advanced interventional treatments — Ketamine Therapy (IV infusion), Ketamine-Assisted Psychotherapy (KAP), Transcranial Magnetic Stimulation (TMS) using MagVenture equipment with FDA-cleared theta burst, and Spravato® (esketamine nasal spray) — supplemented by Talk Therapy/Psychotherapy, EMDR, Medication Management, Telemedicine (via Doxy.me and Zoom), and Vitamin Therapy. These services collectively treat a wide range of conditions including treatment-resistant depression, anxiety, PTSD, OCD, bipolar disorder, ADHD, chronic pain conditions (CRPS, fibromyalgia, migraines, neuropathic pain, RLS), postpartum depression, and suicidal ideation. The practice operates in Naples, Fort Myers, and West Palm Beach, Florida, with a Fast Track to Wellness program offering next-business-day appointments for ketamine and TMS patients.

Differentiator

Problem solved

Functional benefit

Products and services

  • Ketamine Therapy
  • Ketamine-Assisted Psychotherapy
  • TMS Therapy
  • Spravato Treatment
  • EMDR Therapy
  • Talk Therapy (Psychotherapy)
  • Medication Management
  • Telemedicine
  • Vitamin Therapy

Quantifiable outcome

  • 75% of patients find relief through ketamine infusion therapy for depression
  • +3 more outcomes

Companies that use Dura Medical

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Dura Medical technology and API

Technology

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

Feature4 records

Dura Medical partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Hope TherapeuticsminorStrategic or Co-development PartnerPartnership arrangement at West Palm Beach location (1515 N Flagler Dr - Ste 800 West Palm Beach, FL 33407) where Hope Therapeutics operates. Dura Medical maintains presence at this location for patient referrals and services.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Dura Medical competitors and assessment

Company assessment

Broad incumbents

  • Cerebral: Large-scale digital mental health platform offering therapy, medication management, and broader psychiatric services; competes for the same patient segment but as a broader incumbent without Dura Medical's interventional depth.
  • Greenbrook TMS NeuroHealth Centers: National chain operating dedicated TMS treatment centers for depression and OCD; directly comparable on TMS delivery though lacks Dura Medical's ketamine and Spravato offerings.

Direct peers

  • Field Trip Health: Operated multi-city ketamine-assisted psychotherapy and interventional psychiatry clinics before winding down U.S. operations; directly comparable multi-modal treatment model targeting treatment-resistant depression and anxiety.
  • Mindbloom: At-home ketamine therapy platform with clinician-supervised sessions; comparable ketamine-based treatment offering for depression and anxiety, though delivered remotely rather than in clinic.
  • Neuroscience Research Institute / Ketamine Clinics of Southwest Florida: Regional ketamine infusion clinics operating in the same Florida market segment; directly comparable outpatient ketamine delivery model for treatment-resistant depression and pain.
  • Actify Neurotherapies: Multi-location interventional psychiatry practice offering ketamine infusion, TMS, and Spravato with a similar treatment-resistant mental health focus and clinical model.
  • Heading Health: Outpatient interventional psychiatry clinics offering ketamine infusion, Spravato, TMS, and medication management for treatment-resistant conditions — a near-identical service mix to Dura Medical.

Emerging players

  • Brightside Health: Telehealth mental health provider offering medication management and therapy, with growing interventional psychiatry capabilities; partial overlap with Dura Medical's medication management and telemedicine streams.
  • Talkiatry: Online psychiatry platform connecting patients with psychiatrists for medication management and therapy; comparable on the psychiatric care side but lacks Dura Medical's in-clinic interventional modalities.

Regional players

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Dura Medical social profiles

Digital presence

Dura Medical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Dura Medical leadership team

Management profile

Number of profiles

Profiles4 records

Dura Medical funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Dura Medical M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dura Medical

What does Dura Medical do?

Dura Medical is an outpatient behavioral health practice that evaluates and treats patients with depression, PTSD, anxiety, OCD, postpartum depression, bipolar disorder, and chronic pain. It delivers interventional therapies (IV ketamine, ketamine-assisted psychotherapy, TMS, Spravato, vitamin infusions) alongside psychotherapy, EMDR, and medication management, with both in-clinic and telemedicine delivery across its Florida locations.

Is Dura Medical a public or private company?

Dura Medical is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Dura Medical founded?

Dura Medical was founded in 2018. It employs 11 to 50 people.

Where is Dura Medical based?

Dura Medical is headquartered in Naples, United States, in the North America region.

How does Dura Medical make money?

Six revenue lines are on record. Ketamine Infusion Therapy Services are the primary driver. The others are TMS Therapy Services, spravato Treatment, psychotherapy and Counseling, medication Management and telemedicine Services.

Who are Dura Medical's main competitors?

Broad incumbents on record are Cerebral and Greenbrook TMS NeuroHealth Centers. Direct peers are Field Trip Health, Mindbloom, Neuroscience Research Institute / Ketamine Clinics of Southwest Florida, Actify Neurotherapies and Heading Health. Emerging players are Brightside Health and Talkiatry. Compass Behavioral Health / Psychiatric Partners of Southwest Florida is listed as a regional player.

Does Dura Medical have an API?

No public API is recorded for Dura Medical.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswireHOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Complete the Acquisition of Dura Medical; Initial Acquisition in Network of Interventional Psychiatry ClinicsHOPE Therapeutics, a subsidiary of NRx Pharmaceuticals, closed its acquisition of Dura Medical, a Florida-based interventional psychiatry clinic. Dura, which is revenue-generating and EBITDA-positive, will operate with HOPE at over 8 locations along Florida's West Coast. The combined network aims to treat more than 10,000 people by 2026.GlobeNewswireHOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Complete the Acquisition of Dura Medical; Initial Acquisition in Network of Interventional Psychiatry ClinicsHOPE Therapeutics, Inc., a wholly-owned subsidiary of NRx Pharmaceuticals, Inc., has completed the acquisition of Dura Medical, a provider of interventional psychiatry services for severe depression and PTSD based in Florida. Dura Medical, which operates locations in Naples and Ft. Myers, is revenue generating and EBITDA positive, and together with pending acquisitions of Neurospa TMS and Cohen & Associates, will provide coverage at more than 8 locations along Florida's West Coast. Stephen Durand, the founder of Dura Medical and a US Army Veteran, has been appointed as Director of Florida Clinic Operations for HOPE Therapeutics.Business InsiderNRx Pharmaceuticals’ Hope Therapeutics to acquire Dura Medical, no termsHope Therapeutics, owned by NRx Pharmaceuticals, signed a definitive agreement to acquire Dura Medical, following a previously announced non-binding letter of intent. Dura is revenue generating and EBITDA positive, and the acquisition is subject to financial audits, regulatory approvals, and standard closing conditions.Investing.comHOPE Therapeutics expands with Dura Medical acquisition By Investing.comHOPE Therapeutics, Inc., a subsidiary of NRx Pharmaceuticals, Inc., announced the acquisition of Dura Medical, a provider of precision psychiatry services, to expand its interventional psychiatry network in Florida. The acquisition aims to enhance treatments for mental health conditions, including depression and PTSD, leveraging services like ketamine therapy and TMS. The deal is expected to strengthen HOPE's offerings and revenue projections.Mayer BrownDelaware Law Alert: Chancery Court Clarifies Delaware’s Position on Sandbagging and the Use of a Transaction Multiple to Calculate DamagesThe Delaware Chancery Court issued an opinion in In re Dura Medic Holdings, Inc. Consolidated Litigation confirming the state's pro-sandbagging stance and clarifying that damages in M&A disputes can be calculated using a transaction multiple when the purchase price was determined via such a method. The ruling holds that standard integration clauses prevent pre-closing disclosures from modifying representations unless explicitly included in the transaction documents, thereby shifting risk to sellers. This decision provides buyers with greater assurance of indemnification for breaches of representation and warranty even if they had prior knowledge of potential inaccuracies.PR NewswireHOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Announce Dura Medical as the Expected Initial Florida Acquisition for its Planned International Network of Interventional PsychiatrHOPE Therapeutics, Inc., a wholly-owned subsidiary of NRx Pharmaceuticals, Inc., announced a planned acquisition of Dura Medical under a non-binding Letter of Intent, with Dura expected to serve as the first Florida acquisition and cornerstone for HOPE's Southeastern States network. Dura operates clinics in Naples and Fort Myers offering interventional psychiatry services including Ketamine infusion therapy and TMS, and the acquisition is expected to be immediately accretive to revenue and EBITDA for NRx. Stephen Durand, Dura's founder, will join HOPE as Director of Clinical Growth for Florida to help drive statewide expansion.